1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Canada Pharmaceuticals and Healthcare Report Q3 2016

Canada Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 91 pages

Includes 3 FREE quarterly updates

BMI View: Canada has a number of domestic pharmaceutical firms and is a major market for foreignbasedcompanies. Despite the expanding implementation of cost-containment reforms and rising uptake oflower cost generic drugs, the effects of these trends will be mitigated by rising demand for and consumptionof high volumes of prescriptions, particularly high value personalised medicines.Headline Expenditure Projections

- Pharmaceuticals: CAD23.06bn (USD18.04bn) in 2015 to CAD23.53bn (USD17.43bn) in 2016; +2.0%in local currency terms and -3.4% in US dollar terms.

Forecast unchanged from previous quarter.

- Healthcare: CAD209.92bn (USD164.17bn) in 2015 to CAD214.72bn (USD159.05bn) in 2016; +2.3% inlocal currency terms and -3.1% in US dollar terms. Forecast downgraded from previous quarter onaccount of new historical data.

Table Of Contents

Canada Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Canada 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Canada 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Canada 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Canada 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Canada 2014-2020) 29
Industry Risk Reward Index 30
Americas Risk/Reward Index 30
Canada Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 41
Pricing Regime 43
Reimbursement Regime 45
Market Overview 48
Healthcare Sector 48
Table: Healthcare Resources (Canada 2010-2015) 52
Table: Healthcare Personnel (Canada 2010-2015) 52
Table: Healthcare Activity (Canada 2010-2015) 53
Research and Development 53
Clinical Trials 56
Epidemiology 57
Competitive Landscape 60
Research-Based Industry 60
Table: Multinational Market Activity 63
Pharmaceutical Retail Sector 64
Company Profile 66
Apotex 66
GlaxoSmithKline 69
Merck 71
Novartis 73
Valeant 75
Demographic Forecast 80
Demographic Outlook 80
Table: Population Headline Indicators (Canada 1990-2025) 81
Table: Key Population Ratios (Canada 1990-2025) 81
Table: Urban/Rural Population and Life Expectancy (Canada 1990-2025) 82
Table: Population By Age Group (Canada 1990-2025) 82
Table: Population By Age Group % (Canada 1990-2025) 83
Glossary 85
Methodology 87
Pharmaceutical Expenditure Forecast Model 87
Healthcare Expenditure Forecast Model 87
Notes On Methodology 88
Risk/Reward Index Methodology 89
Index Overview 90
Table: Pharmaceutical Risk/Reward Index Indicators 90
Indicator Weightings 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.